A/Prof. Ian Collins

Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM)

L Gately, C Mesía, J Sepúlveda, S del Barco, E Pineda, R Gironés, J Fuster, M Dumas, S Gill, L Navarro, A Herrero, A Dowling, R de las Peñas, M Vaz, M Alonso, Z Lwin, R Harrup, S Peralta, A Long, P Perez-Segura, E Ahern, C Garate, M Wong, R Campbell, K Cuff, R Jennens, O Gallego, C Underhill, M Martinez-Garcia, M Covela, A Cooper, S Brown, M Rosenthal, J Torres, I Collins, P Gibbs, C Balana

(2024), Journal of Neuro-Oncology, C1

A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary

A Posner, O Prall, T Sivakumaran, D Etemadamoghadam, N Thio, A Pattison, S Balachander, K Fisher, S Webb, C Wood, A DeFazio, N Wilcken, B Gao, C Karapetis, M Singh, I Collins, G Richardson, C Steer, M Warren, N Karanth, G Wright, S Williams, J George, R Hicks, A Boussioutas, A Gill, B Solomon, H Xu, A Fellowes, S Fox, P Schofield, D Bowtell, L Mileshkin, R Tothill

(2023), Vol. 259, pp. 81-92, Journal of Pathology, England, C1

Workforce challenges across Victorian medical oncology services

I Collins, R Blum, E Segelov, P Parente, C Underhill

(2023), Vol. 53, pp. 946-950, Internal Medicine Journal, London, Eng., C1

Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary

A Posner, T Sivakumaran, A Pattison, D Etemadmoghadam, N Thio, C Wood, K Fisher, S Webb, A Defazio, N Wilcken, B Gao, C Karapetis, M Singh, I Collins, G Richardson, C Steer, M Warren, N Karanth, A Fellowes, S Fox, R Hicks, P Schofield, D Bowtell, O Prall, R Tothill, L Mileshkin

(2023), Vol. 11, pp. 1-12, Journal for ImmunoTherapy of Cancer, London, Eng., C1

Targeting homologous recombination deficiency in uterine leiomyosarcoma

Genevieve Dall, Cassandra Vandenberg, Ksenija Nesic, Gayanie Ratnayake, Wenying Zhu, Joseph Vissers, Justin Bedő, Jocelyn Penington, Matthew Wakefield, Damien Kee, Amandine Carmagnac, Ratana Lim, Kristy Shield-Artin, Briony Milesi, Amanda Lobley, Elizabeth Kyran, Emily O’Grady, Joshua Tram, Warren Zhou, Devindee Nugawela, Kym Stewart, Reece Caldwell, Lia Papadopoulos, Ashley Ng, Alexander Dobrovic, Stephen Fox, Orla McNally, Jeremy Power, Tarek Meniawy, Teng Tan, Ian Collins, Oliver Klein, Stephen Barnett, Inger Olesen, Anne Hamilton, Oliver Hofmann, Sean Grimmond, Anthony Papenfuss, Clare Scott, Holly Barker

(2023), Vol. 42, pp. 1-20, Journal of Experimental and Clinical Cancer Research, London, Eng., C1

Telehealth in oncology: a cost analysis to evaluate the financial impact of implementing regional trial hubs within a phase 3 cancer clinical trial

Marliese Alexander, Ian Collins, Patrick Abraham, Craig Underhill, Sam Harris, Javier Torres, Sharad Sharma, Benjamin Solomon, An Tran‐Duy, Kate Burbury

(2023), Vol. 53, pp. 2346-2349, Internal Medicine Journal, London, Eng., C1-1

A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma

L Gately, C Mesía, J Sepúlveda, S del Barco, E Pineda, R Gironés, J Fuster, W Hong, M Dumas, S Gill, L Navarro, A Herrero, A Dowling, R de las Peñas, M Vaz, M Alonso, Z Lwin, R Harrup, S Peralta, A Long, P Perez-Segura, E Ahern, C Garate, M Wong, R Campbell, K Cuff, R Jennens, O Gallego, C Underhill, M Martinez-Garcia, M Covela, A Cooper, S Brown, M Rosenthal, J Torres, I Collins, P Gibbs, C Balana

(2023), pp. 1-9, Journal of Neuro-Oncology, Berlin, Germany, C1-1

LINKING DATA FROM A BRAIN CANCER CLINICAL REGISTRY (BRAIN) WITH THE STATE-BASED REGISTRY OF BIRTHS DEATHS MARRIAGES: IMPROVING THE QUALITY OF CLINICAL REGISTRY SURVIVAL DATA

Samuel Smith, Kate Drummond, Anthony Dowling, Iwan Bennett, Ronnie Freilich, Claire Phillips, Elizabeth Ahern, Simone Reeves, Robert Campbell, Ian Collins, Julie Johns, Megan Dumas, Peter Gibbs, Lucy Gately

(2023), Vol. 25, Neuro-Oncology, Oxford, Eng., C1

Prostate cancer survival in South West Victoria

N Chilko, S Dean, L Matheson, R Grills, A Davidson, P Kearns, D Campbell, M Rogers, I Collins

(2022), Vol. 30, pp. 676-682, Australian Journal of Rural Health, Australia, C1

Beyond standard data collection - the promise and potential of BRAIN (Brain tumour Registry Australia INnovation and translation registry)

L Gately, K Drummond, M Rosenthal, R Harrup, A Dowling, A Gogos, Z Lwin, I Collins, D Campbell, E Ahern, C Phillips, H Gan, I Bennett, O Sieber, P Gibbs

(2022), Vol. 22, BMC Cancer, England, C1

Uncertainty and the unmet informational needs of patients with cancer of unknown primary (CUP): a cross-sectional multi-site study

L Guccione, K Fisher, L Mileshkin, R Tothill, D Bowtell, S Quinn, A DeFazio, C Karapetis, N Wilcken, M Singh, C Steer, B Gao, M Warren, I Collins, N Karanth, C Bryant, P Schofield

(2022), Vol. 30, pp. 8217-8229, Supportive Care in Cancer, Germany, C1-1

Uptake of bone modifying agents in patients with HER2+ metastatic breast cancer with bone metastases - prospective data from a multi-site Australian registry

Vanessa Wong, Richard Boer, Catherine Dunn, Angelyn Anton, Laeeq Malik, Sally Greenberg, Belinda Yeo, Louise Nott, Ian COLLINS, Javier Torres, Frances Barnett, Michelle Nottage, Peter Gibbs, Sheau Lok

(2021), pp. 1-21, Internal medicine journal, Chichester, Eng., C1

Real-world impact of anti-HER2 therapy-related cardiotoxicity in patients with advanced HER2-positive breast cancer

C Conduit, R de Boer, S Lok, P Gibbs, L Malik, Z Loh, B Yeo, S Greenberg, B Devitt, J Lombard, M Nottage, I Collins, J Torres, M Nolan, L Nott

(2020), Vol. 16, pp. 356-362, Asia-Pacific Journal of Clinical Oncology, Chichester, Eng., C1

Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer

Y Kanjanapan, S Lok, P Gibbs, R De Boer, B Yeo, S Greenberg, F Barnett, L Knott, G Richardson, R Wong, M Nottage, I Collins, J Torres, J Lombard, J Johns, M Harold, L Malik

(2020), Vol. 184, pp. 87-95, Breast cancer research and treatment, Cham, Switzerland, C1

Consumer and clinician perspectives on personalising breast cancer prevention information

L Keogh, E Steel, P Weideman, P Butow, I Collins, J Emery, G Mann, A Bickerstaffe, A Trainer, L Hopper, K Phillips

(2019), Vol. 43, pp. 39-47, The breast, Amsterdam, The Netherlands, C1

Tailored NEOadjuvant epirubicin, cyclophosphamide and Nanoparticle Albumin-Bound paclitaxel for breast cancer: the phase II NEONAB trial-clinical outcomes and molecular determinants of response

Caitlin Murphy, Andrea Muscat, David Ashley, Violet Mukaro, Linda West, Yang Liao, David Chisanga, Wei Shi, Ian Collins, Sally Baron-Hay, Sujata Patil, Geoffrey Lindeman, Mustafa Khasraw

(2019), Vol. 14, pp. 1-20, PLoS one, San Francisco, Calif., C1

Accuracy of risk estimates from the iPrevent breast cancer risk assessment and management tool

Kelly-Anne Phillips, Yuyan Liao, Roger Milne, Robert MacInnis, Ian Collins, Richard Buchsbaum, Prue Weideman, Adrian Bickerstaffe, Stephanie Nesci, Wendy Chung, Melissa Southey, Julia Knight, Alice Whittemore, Gillian Dite, David Goldgar, Graham Giles, Gord Glendon, Jack Cuzick, Antonis Antoniou, Irene Andrulis, Esther John, Mary Daly, Saundra Buys, John Hopper, Mary Terry

(2019), Vol. 3, pp. 1-9, JNCI cancer spectrum, Oxford, Eng., C1

Implementation of the Australasian teletrial model: lessons from practice

Sabe Sabesan, John Zalcberg, Craig Underhill, Rob Zielinski, Kate Burbury, Zia Ansari, Natalie Rainey, Ian Collins, Richard Osbourne, Jasotha Sanmugarajah, Anthony Joshua, Florian Honeyball

(2019), Vol. 15, pp. 3-14, Asia-Pacific journal of clinical oncology, Chichester, Eng., C1

Influence of socioeconomic factors and distance to radiotherapy on breast-conserving surgery rates for early breast cancer in regional Australia; implications of change

I Collins, C Lum, V Versace

(2018), Vol. 14, pp. e224-e230, Asia-Pacific journal of clinical oncology, Chichester, Eng., C1

The iPrevent online breast cancer risk assessment and risk management tool: usability and acceptability testing

Louisa Lo, Ian Collins, Mathias Bressel, Phyllis Butow, Jon Emery, Louise Keogh, Prue Weideman, Emma Steel, John Hopper, Alison Trainer, Gregory Mann, Adrian Bickerstaffe, Antonis Antoniou, Jack Cuzick, Kelly-Anne Phillips

(2018), Vol. 2, pp. 1-11, JMIR formative research, Toronto, Ont., C1

Mapping the EORTC-QLQ-C30 to the EQ-5D-3L: an assessment of existing and newly developed algorithms

Fionn Woodcock, Brett Doble, CANCER 2015 Consortium, Stephen Fox, Ian Collins, Theresa Hayes, Madhu Singh, Gary Richardson, Lara Lipton, So-Young Moon, Mark Lucas, Andrew Fellowes, Huiling Xu, Heather Thorne, John McNeil, Paula Lorgelly, David Thomas, Paul James, Tomas John, Gail Risbridger, Raymond Snyder

(2018), Vol. 38, pp. 954-967, Medical decision making, London, Eng., C1

Transitioning to routine breast cancer risk assessment and management in primary care: what can we learn from cardiovascular disease?

K Phillips, E Steel, I Collins, J Emery, M Pirotta, B Mann, P Butow, J Hopper, A Trainer, J Moreton, A Antoniou, J Cuzick, L Keogh

(2016), Vol. 22, pp. 255-261, Australian journal of primary health, Clayton, Vic., C1-1

A discrete choice experiment to examine the preferences of patients with cancer and their willingness to pay for different types of health care appointments

S Wong, R Norman, T Dunning, D Ashley, M Khasraw, T Hayes, I Collins, P Lorgelly

(2016), Vol. 14, pp. 311-319, Journal of the national comprehensive cancer network, Cold Spring Harbor, N.Y., C1

Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations

K Phillips, I Collins, R Milne, S McLachlan, M Friedlander, M Hickey, C Stern, J Hopper, R Fisher, G Kannemeyer, S Picken, C Smith, T Kelsey, R Anderson

(2016), Vol. 31, pp. 1126-1132, Human reproduction, Oxford, Eng., C1

Women's preferences for selective estrogen reuptake modulators: An investigation using protection motivation theory

A Ralph, B Ager, M Bell, I Collins, L Andrews, K Tucker, K Phillips, P Butow

(2014), Vol. 96, pp. 106-112, Patient Education and Counseling, Amsterdam, The Netherlands, C1-1

Women's preferences for selective estrogen reuptake modulators: an investigation using the time trade off technique

A Ralph, B Ager, M Bell, I Collins, L Andrews, K Tucker, N O'Reilly, K Phillips, P Butow

(2014), Vol. 3, pp. 1-9, SpringerPlus, Berlin, Germany, C1-1

Assessing and managing breast cancer risk: Clinicians' current practice and future needs

I Collins, E Steel, G Mann, J Emery, A Bickerstaffe, A Trainer, P Butow, M Pirotta, A Antoniou, J Cuzick, J Hopper, K Phillips, L Keogh

(2014), Vol. 23, pp. 644-650, The Breast, Amsterdam, The Netherlands, C1-1

The clinical significance of biochemical failure in the first 2 years in patients treated with neo-adjuvant androgen deprivation and radiotherapy for prostate cancer

F Kelleher, M Dunne, I Collins, M Finn, C O'Shea, J Armstrong

(2013), Vol. 1, pp. 1-7, Oncology discovery, Telangana, India, C1

Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers

I Collins, R Milne, P Weideman, S McLachlan, M Friedlander, C Kathleen Cuningham Foundation Consortium For Resea, J Hopper, K Phillips

(2013), Vol. 199, pp. 680-683, Medical journal of Australia, Sydney, N.S.W., C1-1

Do BRCA1 and BRCA2 mutation carriers have earlier natural menopause than their noncarrier relatives? Results from the Kathleen Cuningham foundation consortium for research into familial breast cancer

I Collins, R Milne, S McLachlan, M Friedlander, M Hickey, P Weideman, K Birch, J Hopper, K Phillips

(2013), Vol. 31, pp. 3920-3925, Journal of Clinical Oncology, San Antonio, TX, C1-1

Clinical decision aids in colon cancer: a comparison of two predictive nomograms

I Collins, F Kelleher, C Stuart, M Collins, J Kennedy

(2012), Vol. 11, pp. 138-142, Clinical colorectal cancer, New York, N.Y., C1-1

Electronic clinical decision support systems attitudes and barriers to use in the oncology setting

I Collins, O Breathnach, P Felle

(2012), Vol. 181, pp. 521-525, Irish journal of medical science, London, Eng., C1-1

A role for IGF-1R-targeted therapies in small-cell lung cancer?

K Gately, I Collins, L Forde, B Al-Alao, V Young, M Gerg, F Feuerhake, K O'Byrne

(2011), Vol. 12, pp. 38-42, Clinical Lung Cancer, United States, C1-1

Terminology and details of the diagnostic process for testis cancer

S Connolly, P Daly, M Floyd, I Collins, R Grainger, J Thornhill

(2011), Vol. 185, pp. 876-880, Journal of Urology, United States, C1-1

Novel approaches to treatment of leiomyosarcomas

I Collins, D Thomas

(2011), Vol. 13, pp. 316-322, Current Oncology Reports, United States, C1-1

Carboplatin Dosing in Ovarian Cancer: Problems and Pitfalls

Ian Collins, Rachel Roberts-Thomson, David Faulkner, Danny Rischin, Michael Friedlander, Linda Mileshkin

(2011), Vol. 21, pp. 1213-1213, International Journal of Gynecological Cancer, C1-1

Strategies for fertility preservation after chemotherapy: Awareness among Irish cancer specialists

I Collins, L Fay, M Kennedy

(2011), Vol. 104, pp. 6-9, Irish Medical Journal, Ireland, C1-1

A lung cancer responding to hormonal therapy

I Collins, S Nicholson, K O'Byrne

(2010), Vol. 5, pp. 749-750, Journal of thoracic oncology, Amsterdam, The Netherlands, C1-1

Divergent cyclisations of 2-(5-amino-4-carbamoyl-1H-pyrazol-3-yl) acetic acids with formyl and acetyl electrophiles

Lynette Smyth, Thomas Matthews, Peter Horton, Michael Hursthouse, Ian Collins

(2007), Vol. 63, pp. 9627-9634, TETRAHEDRON, C1

Rapid evolution of 6-phenylpurine inhibitors of protein kinase B through structure-based design

Alastair Donald, Tatiana McHardy, Martin Rowlands, Lisa-Jane Hunter, Thomas Davies, Valerio Berdini, Robert Boyle, G Aherne, Michelle Garrett, Ian Collins

(2007), Vol. 50, pp. 2289-2292, JOURNAL OF MEDICINAL CHEMISTRY, C1

A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera

Thomas Davies, Marcel Verdonk, Brent Graham, Susanne Saalau-Bethell, Christopher Hamlett, Tatiana McHardy, Ian Collins, Michelle Garrett, Paul Workman, Steven Woodhead, Harren Jhoti, David Barford

(2007), Vol. 367, pp. 882-894, JOURNAL OF MOLECULAR BIOLOGY, C1

A duplexed phenotypic screen for the simultaneous detection of inhibitors of the molecular chaperone heat shock protein 90 and modulators of cellular acetylation

Anthea Hardcastle, Peter Tomlin, Clair Norris, Juliet Richards, Matthew Cordwell, Katherine Boxall, Martin Rowlands, Keith Jones, Ian Collins, Edward McDonald, Paul Workman, Wynne Aherne

(2007), Vol. 6, pp. 1112-1122, MOLECULAR CANCER THERAPEUTICS, C1

Synthesis of 4-(cyclic dialkylamino)-7-azaindoles by microwave heating of 4-halo-7-azaindoles and cyclic secondary amines

John Caldwell, Kwal-Ming Cheung, Ian Collins

(2007), Vol. 48, pp. 1527-1529, TETRAHEDRON LETTERS, C1

Rapid synthesis of 4-benzyl-4-aminopiperidines by addition of Grignard reagents to N-(1-Boc-piperidin-4-ylidene)-tert-butanesulfinyl imine

John Caldwell, Ian Collins

(2006), pp. 2565-2568, SYNLETT, C1

Design and development of signal transduction inhibitors for cancer treatment: Experience and challenges with kinase targets

Ian Collins, Paul Workman

(2006), Vol. 1, pp. 13-23, CURRENT SIGNAL TRANSDUCTION THERAPY, C1-1